Gene · 92170
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Delineating the Spectrum of Genetic Variants Associated with Bardet-Biedl Syndrome in Consanguineous Pakistani Pedigrees. | Genes (Basel) | 2023 | 36833331 | PubTator, text mining | PubMed |
| Photothermal Attenuation of Cancer Cell Stemness, Chemoresistance, and Migration Using CD44-Targeted MoS2 Nanosheets. | Nano Lett | 2023 | 36827209 | PubTator, text mining | PubMed |
| Stiff matrix induces exosome secretion to promote tumour growth. | Nat Cell Biol | 2023 | 36797475 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
| Comparative Study on the Sensing Kinetics of Carbon and Nitrogen Nutrients in Cancer Tissues and Normal Tissues Based Electrochemical Biosensors. | Molecules | 2023 | 36771115 | PubTator, text mining | PubMed |
| Effect of Musical Stimulation on Placental Programming and Neurodevelopment Outcome of Preterm Infants: A Systematic Review. | Int J Environ Res Public Health | 2023 | 36768104 | PubTator, text mining | PubMed |
| MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. | Cancers (Basel) | 2023 | 36765665 | PubTator, text mining | PubMed |
| Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 36765583 | PubTator, text mining | PubMed |
| The Rab GTPase-binding protein EHBP1L1 and its interactors CD2AP/CIN85 negatively regulate the length of primary cilia via actin remodeling. | J Biol Chem | 2023 | 36754282 | PubTator, text mining | PubMed |
| circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR. | Oncogene | 2023 | 36732659 | PubTator, text mining | PubMed |
Protocol for treating lumbar spinal canal stenosis with a combination of ultrapurified, allogenic bone marrow-derived mesenchymal stem cells and in situ-forming gel: a multicentre, prospective, double-blind randomised controlled trial. | BMJ Open | 2023 | 36731929 | PubTator, text mining | PubMed |
| Overexpression of mTOR in Leukocytes from ALS8 Patients. | Curr Neuropharmacol | 2023 | 36722478 | PubTator, text mining | PubMed |
| Discussion on the Clinical Course of Adverse Effects after COVID-19 Vaccination: A Retrospective Analysis of Case Series in an Outpatient Department. | Korean J Fam Med | 2023 | 36709958 | PubTator, text mining | PubMed |
| Screening and validating of endogenous reference genes in Chlorella sp. TLD 6B under abiotic stress. | Sci Rep | 2023 | 36707665 | PubTator, text mining | PubMed |
| Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia. | BMC Med Genomics | 2023 | 36703207 | PubTator, text mining | PubMed |
| A nucleotide binding-independent role for γ-tubulin in microtubule capping and cell division. | J Cell Biol | 2023 | 36695784 | PubTator, text mining | PubMed |
| Pneumatosis Cystoides Intestinalis: A Case Report. | Am J Case Rep | 2023 | 36694439 | PubTator, text mining | PubMed |
| Pan-Cancer Study on Variants of Canonical miRNA Biogenesis Pathway Components: A Pooled Analysis. | Cancers (Basel) | 2023 | 36672288 | PubTator, text mining | PubMed |
| A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules. | Chem Rev | 2023 | 36662637 | PubTator, text mining | PubMed |
| GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey. | Epilepsy Behav Rep | 2023 | 36654732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92170/papers?page=12